* Protagenic Therapeutics (NASDAQ:PTIX [https://seekingalpha.com/symbol/PTIX]) announced on Friday that it expects to file its Quarterly Report on Form 10-Q for the period ended June 30, 2025, in the near future, following a delay attributable to the completion of merger-related consolidation of financial statements, including purchase accounting adjustments, pro forma financial information, and related disclosures.
* The company anticipates this delay to be brief, there can be no assurance as to the definitive timing of the filing.
* Protagenic also confirmed a receipt of Nasdaq notice in connection with the company's failure to file its Quarterly Report on Form 10-Q for the period ended June 30, 2025.
* The notice has no immediate effect on the listing or trading of Protagenic's securities, which continue to trade on the Nasdaq Capital Market under the symbol "PTIX."
* PTIX +1.41% after hours to $4.3.
* Source: Press Release [https://seekingalpha.com/pr/20209506-protagenic-therapeutics-provides-update-on-form-10-q-filing-timeline-and-nasdaq-compliance]
MORE ON PROTAGENIC THERAPEUTICS
* Financial information for Protagenic Therapeutics [https://seekingalpha.com/symbol/PTIX/income-statement]
Protagenic Therapeutics provides update on Form 10-Q filing timeline and Nasdaq compliance
Published 2 months ago
Aug 22, 2025 at 9:37 PM
Positive
Auto